<- Go Home
DexCom, Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$31.0B
Volume
4.0M
Cash and Equivalents
$621.2M
EBITDA
$840.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.4B
Profit Margin
61.68%
52 Week High
$142.00
52 Week Low
$62.34
Dividend
N/A
Price / Book Value
15.65
Price / Earnings
47.56
Price / Tangible Book Value
16.75
Enterprise Value
$31.1B
Enterprise Value / EBITDA
35.57
Operating Income
$628.0M
Return on Equity
32.06%
Return on Assets
6.06
Cash and Short Term Investments
$2.5B
Debt
$2.6B
Equity
$2.0B
Revenue
$4.0B
Unlevered FCF
$365.1M
Sector
Health Care Equipment and Supplies
Category
N/A
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick Premium